glycerin 200 MG/ML / lidocaine 43 MG/ML [Recticare Wipes]

RxCUI
1602015
RxNorm name
glycerin 200 MG/ML / lidocaine 43 MG/ML [Recticare Wipes]
Term type
SBDC
Status
Active
Updated
2026-10-17 23:57:34

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
032015
Active start
032015
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
200 MG / 1 MLglycerin
43 MG / 1 MLlidocaine

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
glycerin4910
lidocaine6387

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRglycerin 200 MG/ML / lidocaine 43 MG/ML [Recticare Wipes]1NAMES
RxNorm Nameglycerin 200 MG/ML / lidocaine 43 MG/ML [Recticare Wipes]1NAMES
TTYSBDC1ATTRIBUTES
RxCUI16020151CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN01BBAmidesATC1-4lidocaine
ATCS02DAAnalgesics and anestheticsATC1-4lidocaine
ATCD04ABAnesthetics for topical useATC1-4lidocaine
ATCR02ADAnesthetics, localATC1-4lidocaine
ATCC01BBAntiarrhythmics, class IbATC1-4lidocaine
ATCA06AGEnemasATC1-4glycerin
ATCS01HALocal anestheticsATC1-4lidocaine
ATCC05ADLocal anestheticsATC1-4lidocaine
ATCA06AXOther drugs for constipationATC1-4glycerin
FDASPLD000485AllergensCHEMhas_chemical_structureglycerin
FDASPLD005990GlycerolCHEMhas_chemical_structureglycerin
FDASPLN0000175682Amide Local AnestheticEPChas_epclidocaine
FDASPLN0000175426AntiarrhythmicEPChas_epclidocaine
FDASPLN0000185370Non-Standardized Chemical AllergenEPChas_epcglycerin
FDASPLN0000184306Cell-mediated ImmunityPEhas_peglycerin
FDASPLN0000175629Increased Histamine ReleasePEhas_peglycerin
FDASPLN0000185001Increased IgG ProductionPEhas_peglycerin
FDASPLN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTD005990GlycerolCHEMhas_ingredientglycerin
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine
MEDRTD002056BurnsDISEASEmay_treatlidocaine
MEDRTD003248ConstipationDISEASEmay_treatglycerin
MEDRTD003872DermatitisDISEASEmay_treatglycerin
MEDRTD003872DermatitisDISEASEmay_preventglycerin
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine
MEDRTD004342Drug HypersensitivityDISEASEci_withglycerin
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine
MEDRTD006967HypersensitivityDISEASEci_withlidocaine
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine
MEDRTD010146PainDISEASEmay_treatlidocaine
MEDRTD010146PainDISEASEmay_preventlidocaine
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine
MEDRTN0000000075Stool Bulking ActivityMOAhas_moaglycerin
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000009035Emollient ActivityPEhas_peglycerin
MEDRTN0000009371Increased Large Intestinal MotilityPEhas_peglycerin
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTN0000009870Stimulation Large Intestine Fluid/Electrolyte AbsorptionPEhas_peglycerin

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESRXNAV_HUMAN_DRUGUS